课题基金 / 基金详情

Nanoparticle formulations for DNA-targeted radiotherapy and imaging: combinations with chromatin-modifying compounds

Nanoparticle formulations for DNA-targeted radiotherapy and imaging: combinations with chromatin-modifying compounds
用于 DNA 靶向放射治疗和成像的纳米颗粒制剂:与染色质修饰化合物的组合
批准号:
FT120100942
负责人:
Dr Tom Karagiannis
金额:
$51.77万
依托单位国家:
澳大利亚
项目类别:
ARC Future Fellowships
财政年份:
2012
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2012-09-01 至 2016-08-31

项目摘要

项目成果

Dr Tom Karagiannis的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This project will develop a new approach for treating and imaging cancer using nanoparticles which target specific cells for cancer therapy and diagnostic imaging. The nanoparticles will be combined with compounds that alter the architecture of DNA to make therapy more effective and to improve the safety of imaging.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DNA binding ligands for Auger therapy and receptor imaging
  • 批准号:
    nhmrc : 566559
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $39.31万
  • 财政年份:
    2009
  • 负责人:
    Dr Tom Karagiannis
  • 依托单位:
海外基金